You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The agreement follows a number of other distribution deals Bioké has signed in recent months including ones with Omni Life Science, Syntec, and Namocell.
Bioké has signed a number of recent distribution deals covering the the Netherlands, Belgium, and Luxembourg including ones with Syntec and Namocell.
Bioké will distribute Ireland-based Syntec's Medimachine semi-automated homogenizer products in the Netherlands, Belgium, and Luxembourg.
NEW YORK (GenomeWeb News) – RainDance Technologies and Bioke today announced a distribution deal covering parts of Europe.
Bioké has signed an agreement to distribute Trinean products in the Netherlands and Germany, the firms announced today.
NEW YORK (GenomeWeb News) – Bioké and Advanced Cell Diagnostics today announced a distribution deal covering the Benelux region.
NEW YORK (GenomeWeb News) – Gen-Probe disclosed in its annual 2011 earnings document that it has lost almost $41 million in its investment in Pacific Biosciences as of the end of 2011.
The firm inked deals with distributors in the Netherlands and India.
The European office is the third CST has created outside its home base since 2008. Meanwhile, the restructuring of its PhosphoScan services business is expected to bring in between $10 million and $20 million in revenues in five years.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.